DewCell

BiotechnologySeries CSeongnam, South Koreadewcellbio.com

Latest round

Series C

Last raised

Mar 2026

Total raised

$22M

Investors

12

About DewCell

Founded in 2021 and based in Seongnam, South Korea, DewCell operates as a biotechnology company that is developing artificial platelets using human-derived stem cell-induced differentiation technology and biomimetic technology to solve the blood donation shortage problem. The company’s pipeline includes the En-aPLT™ platform for manufacturing artificial platelets derived from stem cells and the i-aPLP™ platform for creating induced pluripotent stem cell-derived artificial platelet analogues. Dewcell is advancing i-ahPLys™, which is a technology for producing artificial human platelet lysate from induced pluripotent stem cells.

Who invested in DewCell

12 investors across 3 rounds

See all investors in DewCell

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 29, 2026

    Amount

    $16M

    Investors

    Locked

  2. Series B

    Apr 29, 2024

    Amount

    $6.5M

    Investors

    Locked

  3. Seed

    Feb 1, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about DewCell

Who invested in DewCell?

DewCell has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has DewCell raised?

DewCell has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did DewCell last raise money?

DewCell's most recent round on record is a Series C, in Mar 2026.

What does DewCell do?

Founded in 2021 and based in Seongnam, South Korea, DewCell operates as a biotechnology company that is developing artificial platelets using human-derived stem cell-induced differentiation technology and biomimetic technology to solve the blood donation shortage problem.

Where is DewCell headquartered?

DewCell is headquartered in Seongnam, South Korea.

Which VCs invest in companies like DewCell?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at DewCell's stage. Their profiles are linked below.

Raising like DewCell? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.